THE PROTECTIVE EFFECTS OF TYPE-1 INTERFERON IN MODELS OF INTESTINAL INFLAMMATION
Inflammatory bowel disease (IBD) including both Crohn’s disease and ulcerative colitis is characterized by episodes of intestinal inflammation that can reoccur throughout life. Clinical and experimental evidence suggests that the etiology of IBD is multifactorial and includes susceptibility genes related to innate immunity (e.g., Nod2, IL-23R) as well as environmental factors,4, 5, 6,10,13,14 such as exposure to intestinal microflora and/or their products. It is believed that the interaction of these factors with the immune system leads to dysregulated mucosal immunity and chronic intestinal inflammation. Different models of experimental colitis have been instrumental in defining the fundamental molecular mechanisms and cellular interplay that lead to colonic inflammation in mice as well as humans.
The acute colitis that is induced in mice by a single oral administration of dextran sulfate sodium (DSS) is the result of a T cell independent inflammatory reaction. This...
KeywordsInflammatory Bowel Disease Dextran Sulfate Sodium Intestinal Inflammation TLR9 Ligand Diphtheria Toxin
This work was supported by NIH grants AI40682, AI68685, DK35108 and a grant from the CCFA. We thank Mrs. L. Beck for her editorial assistance.
- 1.Abe K, Nguyen KP, Fine SD, Mo J-H, Shen C, Shenouda S, Corr M, Jung S, Lee J, Eckmann L, Raz E (2007) Conventional dendritic cells regulate the outcome of colonic inflammation independently of T cells. Proc Natl Acad Sci USA (in press )<bib id="bib1"> <no>1.</no> Abe K, Nguyen KP, Fine SD, Mo J-H, Shen C, Shenouda S, Corr M, Jung S, Lee J, Eckmann L, Raz E (2007) Conventional dendritic cells regulate the outcome of colonic inflammation independently of T cells. Proc Natl Acad Sci USA (in press<auQuery ID="AU2">[AU2]</auQuery>)</bib> Google Scholar
- 5.Duerr RH, Taylor KD, Brant SR, Rioux JD, Silverberg MS, Daly MJ, Steinhart AH, Abraham C, Regueiro M, Griffiths A, Dassopoulos T, Bitton A, Yang H, Targan S, Datta LW, Kistner EO, Schumm LP, Lee AT, Gregersen PK, Barmada MM, Rotter JI, Nicolae DL, Cho JH (2006)A genome-wide association study identifies IL23R as an inflammatory bowel disease gene. Science 314:1461–1463CrossRefPubMedGoogle Scholar
- 6.Hugot JP, Chamaillard M, Zouali H, Lesage S, Cezard JP, Belaiche J, Almer S, Tysk C, O’Morain CA, Gassull M, Binder V, Finkel Y, Cortot A, Modigliani R, Laurent-Puig P, Gower-Rousseau C, Macry J, Colombel JF, Sahbatou M, Thomas G (2001) Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn’s disease. Nature 411:599–603CrossRefPubMedGoogle Scholar
- 7.Jung S, Unutmaz D, Wong P, Sano G, De los Santos K, Sparwasser T, Wu S, Vuthoori S, Ko K, Zavala F, Pamer EG, Littman DR, Lang RA (2002) In vivo depletion of CD11c(+) dendritic cells abrogates priming of CD8(+) T cells by exogenous cell-associated antigens. Immunity 17:211–220CrossRefPubMedGoogle Scholar
- 9.Lee J, Mo JH, Katakura K, Alkalay I, Rucker AN, Liu YT, Lee HK, Shen C, Cojocaru G, Shenouda S, Kagnoff M, Eckmann L, Ben-Neriah Y, Raz E (2006) Maintenance of colonic homeostasis by distinctive apical TLR9 signalling in intestinal epithelial cells. Nat Cell Biol 8:1327–1336CrossRefPubMedGoogle Scholar
- 10.Ogura Y, Bonen DK, Inohara N, Nicolae DL, Chen FF, Ramos R, Britton H, Moran T, Karaliuskas R, Duerr RH, Achkar JP, Brant SR, Bayless TM, Kirschner BS, Hanauer SB, Nunez G, Cho JH (2001) A frameshift mutation in NOD2 associated with susceptibility to Crohn’s disease. Nature 411:603–606CrossRefPubMedGoogle Scholar